Search

Your search keyword '"Canonica, GW"' showing total 1,261 results

Search Constraints

Start Over You searched for: Author "Canonica, GW" Remove constraint Author: "Canonica, GW"
1,261 results on '"Canonica, GW"'

Search Results

1. Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study

2. Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study

3. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy

5. Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma

6. A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)

7. Clinical Evolution and Quality of Life in Clinically Based COPD Chronic Bronchitic and Emphysematous Phenotypes: Results from the 1-Year Follow-Up of the STORICO Italian Observational Study

8. Overcoming Barriers to the Effective Management of Severe Asthma in Italy

9. One-Year Evolution of Symptoms and Health Status of the COPD Multi-Dimensional Phenotypes: Results from the Follow-Up of the STORICO Observational Study

10. Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry

11. Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study

12. Targeted therapy in severe asthma today: focus on immunoglobulin E

15. An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options

16. Switching treatments in COPD: implications for costs and treatment adherence

17. Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab

20. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy

21. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

22. The prevalence of sleep impairments and predictors of sleep quality among patients with asthma

23. Real-world data: come possono aiutare a migliorare la qualità dell’assistenza

24. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines

25. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.

26. Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities.

27. Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma

28. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper (vol 12, 100080, 2020)

29. Real-world data: how they can help to improve quality of care

30. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

31. Is diet partly responsible for differences in COVID-19 death rates between and within countries? (vol 10, 16, 2020)

32. Efficacy and safety of treatment with dupilumab for severe asthma : A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

33. International Severe Asthma Registry Mission Statement

34. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

35. ARIA-EAACI Statement on Asthma and COVID-19

36. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

37. International severe asthma registry (ISAR): protocol for a global registry

38. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020

39. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

40. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

41. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.

42. Characteristics and treatment regimens across ERS SHARP severe asthma registries

43. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

45. Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® In the Management of Asthma) study

46. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

47. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

50. Diagnosis and management of moderate to severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA)

Catalog

Books, media, physical & digital resources